about
Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study.Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritisTNFalpha blockade in human diseases: an overview of efficacy and safety.Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.Additive combination of actarit and methotrexate in the treatment of refractory rheumatoid arthritis.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Rational use of disease-modifying antirheumatic drugs.
@en
Rational use of disease-modifying antirheumatic drugs.
@nl
type
label
Rational use of disease-modifying antirheumatic drugs.
@en
Rational use of disease-modifying antirheumatic drugs.
@nl
prefLabel
Rational use of disease-modifying antirheumatic drugs.
@en
Rational use of disease-modifying antirheumatic drugs.
@nl
P1433
P1476
Rational use of disease-modifying antirheumatic drugs.
@en
P2093
P356
10.2165/00003495-199039010-00003
P577
1990-01-01T00:00:00Z
P6179
1010300249